Clinical Trial Update: Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing sirolimus-eluting versus everolimus-eluting coronary stents in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Everolimus-eluting stent (everolimus-eluting stent)
• Sirolimus-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: Takeshi Morimoto | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED